APP and Alzheimer disease: Zhang et al. show that histone acetylation is significantly decreased in the temporal lobe of patients with AD compared with that of controls, which is consistent with the previous finding in an APP/PS1 mouse model of AD, highlighting that histone acetylation is involved in AD (99, 100).